Baltimore, United States
CoapTech, founded in 2016 and headquartered in the United States, is at the forefront of medical innovation in the Biotechnology and Health Care sectors. Their slogan, The PUMA System: Minimally invasive surgical devices enabling point-of-care ultrasound procedures in hollow organs, aptly encapsulates their mission to revolutionize medical procedures through breakthrough technology.
The company leverages its patented Point-of-care Ultrasound Magnet Aligned (PUMA) System to enhance various medical procedures by improving cost efficiency, safety, and access to care. Invented by Dr. Steven Tropello, the system allows diagnostic and therapeutic interventions in hollow organs, combining magnetic guidance with affordable, readily available ultrasound technology.
Their flagship product, the PUMA-G, is designed for bedside insertion of gastrostomy tubes, bypassing the need for surgical suites and specialists, thereby offering a sustainable solution for hospitals. The PUMA-G has demonstrated strong commercial potential and adherence to regulatory requirements, as evidenced by streamlined feedback from the FDA.
The company secured a $4.00M debt financing investment on 15 July 2023, underscoring its strategic financial positioning and the industry's confidence in its growth trajectory.
-logo.jpg){kind=logo}
